Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cebranopadol for acute pain after abdominoplasty
NCT06545097Phase 3Completed
- Sponsor
- Tris Pharma
- Start
- Sep 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cebranopadol in acute pain, sponsored by Tris Pharma. Started Sep 2024; status: completed.
02
Drugs
cebranopadol
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT06545097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06545097.